PG Abrams
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- interferon and immune responses 2
- Immunotherapy and Immune Responses 1
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Kenneth A. Foon (7 shared papers)Annette E. Maluish (3 shared papers)J Ochs (2 shared papers)Mehmet F. Fer (1 shared paper)Deborah K. Mayer (1 shared paper)Paul A. Bunn (1 shared paper)R. K. Oldham (2 shared papers)Henry C. Stevenson (1 shared paper)
- Journals
- Blood (2 papers)Cancer Immunology Immunotherapy (2 papers)PubMed (5 papers)
- Partner nations
- United States
In The Last Decade
PG Abrams
9 papers receiving 344 citations
Peers
Comparison fields: 5 of 27
- Radiology, Nuclear Medicine and Imaging 130
- Genetics 34
- Immunology 62
- Pathology and Forensic Medicine 18
- Modeling and Simulation 4
Countries citing papers authored by PG Abrams
This map shows the geographic impact of PG Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PG Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PG Abrams more than expected).
Fields of papers citing papers by PG Abrams
This network shows the impact of papers produced by PG Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PG Abrams. The network helps show where PG Abrams may publish in the future.
Co-authors
The 24 scholars most cited alongside PG Abrams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 139 | |
| 2 | 1985 | 88 | |
| 3 | Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies. | 1989 | 68 |
| 4 | 1986 | 33 | |
| 5 | A phase I evaluation of poly(I,C)-LC in cancer patients. | 1985 | 27 |
| 6 | A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer. | 1984 | 20 |
| 7 | Monoclonal antibody therapy in malignant melanoma: factors effecting in vivo localization. | 1987 | 18 |
| 8 | 1983 | 9 | |
| 9 | Specific targeting of cancer with monoclonal antibodies. Diagnostic and therapeutic applications. | 1990 | 1 |
About PG Abrams
PG Abrams is a scholar working on Immunology, Genetics, Radiology, Nuclear Medicine and Imaging, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 9 papers that have together received 403 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), interferon and immune responses (2 papers), Immunotherapy and Immune Responses (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (130 citations), Genetics (34 citations), Immunology (62 citations), Pathology and Forensic Medicine (18 citations) and Modeling and Simulation (4 citations). PG Abrams has collaborated with scholars based in United States. Frequent co-authors include Kenneth A. Foon, Annette E. Maluish, J Ochs, Mehmet F. Fer, Deborah K. Mayer, Paul A. Bunn, R. K. Oldham, Henry C. Stevenson, R. Herberman and C S Woodhouse. Their work appears in journals such as Blood, Cancer Immunology Immunotherapy and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.